Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates strong financial performance with improved cash flow and debt reduction. The strategic focus on manufacturing expansion, particularly in Vietnam, and new programs in the U.S., Mexico, and Vietnam suggest future growth. The Q&A section highlights demand from new programs and effective tariff strategies. Although there are some concerns about the consignment program's slower ramp-up, the overall sentiment is positive with expectations of breakeven and margin expansion by year-end. The company's strategic initiatives and operational improvements are likely to have a positive impact on the stock price.
Total Revenue (Q2 FY 2026) $96.3 million, a decrease from $113.9 million in Q2 FY 2025 (-15.4%). The decline was due to reduced demand from a long-standing customer and the transition of an end-of-life program, partially offset by new program wins and increased demand from other long-standing customers.
Total Revenue (First 6 months FY 2026) $195.1 million, a decrease from $245.4 million in the same period of FY 2025 (-20.5%). The decline aligns with strategic near-shoring and tariff mitigation strategies.
Gross Margin (Q2 FY 2026) 0.6%, a decrease from 6.8% in Q2 FY 2025. The decline was due to charges for severance, inventory write-offs, and other related expenses from the China facility wind-down and Mexico workforce reductions. Adjusted gross margin was 7.9%.
Operating Margin (Q2 FY 2026) -10.7%, a decrease from -1.0% in Q2 FY 2025. The decline was driven by strategic initiatives and related charges.
Net Loss (Q2 FY 2026) $8.6 million or $0.79 per share, compared to $4.9 million or $0.46 per share in Q2 FY 2025. The increase in net loss was due to reduced revenue and charges related to strategic initiatives.
Net Loss (First 6 months FY 2026) $10.9 million or $1 per share, compared to $3.8 million or $0.35 per share in the same period of FY 2025. The increase in net loss was due to similar factors as Q2.
Adjusted Net Income (Q2 FY 2026) Breakeven ($0.00 per share), compared to an adjusted net loss of $4.1 million or $0.38 per share in Q2 FY 2025. Improvement due to adjustments excluding strategic charges.
Inventory (Q2 FY 2026) Down $12.3 million (-12%) year-over-year, reflecting improved inventory management.
Current Ratio (Q2 FY 2026) 2.0:1, a decrease from 2.8:1 a year ago, indicating changes in liquidity.
Accounts Receivable DSOs (Q2 FY 2026) 77 days, an improvement from 99 days a year ago, reflecting stronger receivables collection.
Cash Flow from Operations (Q2 FY 2026) $6.3 million, an increase from $1.3 million in Q2 FY 2025. The improvement was due to better operational cash management.
Debt Reduction (Year-over-Year) $13.4 million, reflecting improved cash flow and financial management.
Capital Expenditures (Q2 FY 2026) $3.3 million, bringing year-to-date total to $6.5 million. Investments focused on new production equipment and automation.
New program wins: Won new programs in automotive technology, pest control, and industrial equipment. Ramping up a manufacturing services contract with a data processing OEM in Mississippi, which could grow to over $25 million in annual revenue.
Medical products: Shipped the first batch of medical products from Da Nang, Vietnam.
Geopolitical and tariff impact: Shifted manufacturing from China to Vietnam and the U.S. to mitigate tariff uncertainties and geopolitical tensions. Approximately half of manufacturing is expected to take place in the U.S. and Vietnam by the end of FY 2026.
Onshoring trend: Observed a growing trend of onshoring and dual sourcing of contract manufacturing, driven by global tariff wars and geopolitical tensions.
Cost savings initiatives: Winding down China operations and reducing workforce in Mexico, saving $1.2 million and $1.5 million per quarter, respectively. Streamlined operations and invested in automation in Mexico to remain cost-competitive.
Efficiency improvements: Invested in new production equipment and automation, with $6.5 million spent on capital expenditures year-to-date. Anticipate stronger financial performance through enhanced productivity and streamlined supply chains.
Manufacturing footprint shift: Transitioned programs from China to Vietnam and the U.S. to reduce risks associated with tariffs and geopolitical tensions. Expanded Vietnam facility to support medical device manufacturing.
Vertical integration: Invested in advanced manufacturing processes, including plastic molding, PCB assembly, and automated assembly, to differentiate from competitors and enhance design capabilities.
Reduced demand from a long-standing customer: Revenue for Q2 FY 2026 was adversely impacted by reduced demand from a long-standing customer, contributing to a decline in total revenue compared to the same period in FY 2025.
Transition of end-of-life program: The transition of an end-of-life program negatively impacted revenue for Q2 FY 2026.
Global economic uncertainties and volatile trade policies: Customers continue to face uncertainties in the global economy and volatile trade policies, impacting demand and the timing of new program launches.
Wind down of China-based manufacturing operations: The wind down of manufacturing operations in China resulted in significant charges for severance, inventory write-offs, and other related expenses, adversely impacting margins.
Workforce reductions in Mexico: Workforce reductions in Mexico led to severance charges and operational adjustments, which negatively impacted margins in the short term.
Decline in gross and operating margins: Gross margin dropped to 0.6% and operating margin to negative 10.7% in Q2 FY 2026, compared to 6.8% and negative 1.0% in the same period of FY 2025, due to restructuring costs and reduced revenue.
Geopolitical tensions and tariff uncertainties: Ongoing geopolitical tensions and tariff uncertainties have impacted the timing and launch of new programs and necessitated adjustments in the manufacturing footprint.
Delays in new product launches: Global market uncertainties have caused delays in new product launches for the company, its suppliers, and customers.
Increased costs in Mexico: Sustained wage increases in Mexico have necessitated streamlining operations and investing in automation to remain cost-competitive.
Revenue Growth: The company expects revenue growth in the coming quarters from new programs launching in the U.S., Mexico, and Vietnam. They anticipate double-digit growth in their Arkansas facility during the latter half of fiscal 2026.
Margin Improvements: Margins are expected to strengthen as top-line growth returns, driven by improvements in operating efficiencies, cost-saving initiatives, and increased production volumes.
Cost Savings: The wind-down of the China facility and workforce reductions in Mexico are expected to save approximately $1.2 million and $1.5 million per quarter, respectively, once fully implemented.
Capital Expenditures: Capital expenditures for fiscal 2026 are expected to be around $8 million to $10 million, focusing on new production equipment, automation, and efficiency improvements.
Vietnam Facility Growth: The Vietnam facility, which has doubled its manufacturing capacity, is expected to play a major role in growth, particularly in medical device manufacturing.
Onshoring and Nearshoring Trends: The company anticipates benefiting from the trend of onshoring and nearshoring, with approximately half of its manufacturing expected to take place in the U.S. and Vietnam by the end of fiscal 2026.
New Business Opportunities: The company has a strong pipeline of potential new business, driven by geopolitical tensions, tariff uncertainties, and the trend towards dual sourcing and onshoring.
Consigned Material Model: The consigned material model being implemented in the Corinth, Mississippi facility has the potential to grow to over $25 million in annual revenue, significantly improving profitability.
The selected topic was not discussed during the call.
The earnings call summary indicates strong financial performance with improved cash flow and debt reduction. The strategic focus on manufacturing expansion, particularly in Vietnam, and new programs in the U.S., Mexico, and Vietnam suggest future growth. The Q&A section highlights demand from new programs and effective tariff strategies. Although there are some concerns about the consignment program's slower ramp-up, the overall sentiment is positive with expectations of breakeven and margin expansion by year-end. The company's strategic initiatives and operational improvements are likely to have a positive impact on the stock price.
The earnings call presents a mixed outlook. Strong financial metrics and optimistic guidance suggest potential positive movement, but concerns about consumer demand softness, customer bankruptcy, and unclear management responses temper enthusiasm. The consigned materials program shows promise, but its success hinges on external factors. The Vietnam facility's strategic importance is a positive, yet tariff issues and production delays introduce uncertainty. Overall, the sentiment is neutral, reflecting a balanced view of positive growth prospects and existing challenges.
The earnings call reveals a significant revenue decline and increased losses, with reduced demand from key customers. Despite some positive aspects like new business wins and cost-saving measures, the lack of guidance and unclear responses in the Q&A raise concerns. The refusal to provide guidance, especially amidst tariff uncertainties, and weak financial performance overshadow optimistic long-term growth prospects, indicating a negative sentiment.
The earnings call indicates a challenging environment: significant revenue decline, cost increases due to tariffs, and geopolitical tensions. Despite improved gross margins and reduced net losses, the absence of revenue guidance, continued net losses, and lack of a share repurchase program weigh negatively. The Q&A reveals management's evasiveness on key financial metrics and macroeconomic impacts, further contributing to a negative sentiment. While there are new business wins and improved financial management, the overall outlook remains strained, leading to a likely stock price decline of -2% to -8% over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.